JNBA Financial Advisors’s West Pharmaceutical WST Stock Holding History

JNBA Financial Advisors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.87K	Sell	8 -22	-73%	-$6.73K	﹤0.01%	683
2026 Q1	$7.52K	Buy	30 +22	+275%	+$5.47K	﹤0.01%	531
2025 Q4	$2.2K	Hold	8	–	–	﹤0.01%	665
2025 Q3	$2.1K	Hold	8	–	–	﹤0.01%	600
2025 Q2	$1.75K	Hold	8	–	–	﹤0.01%	605
2025 Q1	$1.79K	Hold	8	–	–	﹤0.01%	602
2024 Q4	$2.62K	Hold	8	–	–	﹤0.01%	579
2024 Q3	$2.4K	Hold	8	–	–	﹤0.01%	591
2024 Q2	$2.64K	Hold	8	–	–	﹤0.01%	564
2024 Q1	$3.17K	Hold	8	–	–	﹤0.01%	571
2023 Q4	$2.82K	Hold	8	–	–	﹤0.01%	587
2023 Q3	$3K	Hold	8	–	–	﹤0.01%	594
2023 Q2	$3.06K	Sell	8 -9	-53%	-$3.21K	﹤0.01%	589
2023 Q1	$5.89K	Buy	+17	New	+$4.97K	﹤0.01%	532
2022 Q4	–	Sell	-4	Closed	-$1K	–	705
2022 Q3	$1K	Buy	+4	New	+$1.22K	﹤0.01%	671
2022 Q1	–	Sell	-16	Closed	-$8K	–	863
2021 Q4	$8K	Buy	+16	New	+$6.89K	﹤0.01%	551

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

JNBA Financial Advisors's WST Position: Q2 2026 in Review

JNBA Financial Advisors reduced its West Pharmaceutical (WST) stake by 73% in Q2 2026, selling an estimated $6.73K and leaving 8 shares worth $2.87K. The position accounts for ﹤0.01% of the portfolio, ranked #683.

JNBA Financial Advisors first reported a position in WST in Q4 2021 and has held it in 16 quarters since. The position peaked at $8K in Q4 2021. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

JNBA Financial Advisors held 8 shares of West Pharmaceutical worth $2.87K as of Q2 2026.
JNBA Financial Advisors sold 22 West Pharmaceutical shares in Q2 2026, an estimated $6.73K.
West Pharmaceutical made up ﹤0.01% of JNBA Financial Advisors's portfolio in Q2 2026, its #683 holding.
JNBA Financial Advisors first reported a position in West Pharmaceutical in Q4 2021 and has held it in 16 quarters since.
JNBA Financial Advisors's West Pharmaceutical position peaked at $8K in Q4 2021.
834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on JNBA Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.